《高盛认股证牛熊证》 内险股强势跑赢大市 留意贴价高杠杆平保购27363，高杠杆中寿购17632
板块动向：中国保险行业协会发表报告，今年上半年，共59家公司经营互联网人身险业务，累计实现规模保费达1,394.4亿元人民币，按年升12.2%。保险股今早表现强势。
平保(2318)
正股表现：平保上周五升约0.2%。今早则高开约0.8%後升幅扩大，现报86元，升约3.5%。平保上周公布，今年首七个月，四家控股子公司原保险合同保费收入合共达5,036.91亿元人民币，按年升0.85%。
资金流向：观察个股认股证资金流向，可见上周五资金转向部署认购证，录得约130万元资金流入。
产品选择：投资者如看好，可考虑以行使价85至95元作为筛选认购证的条件。并可留意当中换股比率10兑1、两个月期以上产品中，杠杆最突出之一的贴价平安购27363。并可留意年期约3个月的高敏感度平安购19487。
平安购27363，行使价86.91元，2020年10月22日到期，实际杠杆15.8倍，贴价、行使价85至95元间、换股比率10兑1、两个月期以上产品中，杠杆最高之一
平安购19487，行使价89.94元，2020年11月25日到期，实际杠杆13.3倍，高敏感度、较贴价
中人寿(2628)
正股表现：中人寿上周五升约2%。今早继续上升，早上高开约0.7%後突破20元水平，现报20.05元，升约4.6%。中人寿公布，今年首七个月，累计原保险保费收入约4,551亿元人民币，按年升12.34%。
资金流向：观察个股认股证资金流向，可见近日资金倾向部署认购证，上周四及上周五共录得约370万元资金流入。
产品选择：投资者如看好，可考虑以行使价20至24元、两个月期以上作为筛选认购证的条件。并可留意当中杠杆最突出之一的贴价中寿购23032，及杠杆最突出的价外中寿购17632。
中寿购23032，行使价20.83元，2020年11月13日到期，实际杠杆7.3倍，贴价，行使价20至24元间、两个月期以上产品中，杠杆最高之一
中寿购17632，行使价23.28元，2020年12月23日到期，实际杠杆7.6倍，价外，行使价20至24元间、两个月期以上产品中，杠杆最高
注: 以上数据资料来自高盛认股证牛熊证网站~
重要声明:
以上资讯由第三方提供，AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告，不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料，本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
